JP2013538827A - 腎機能を増強させるための組成物および方法 - Google Patents
腎機能を増強させるための組成物および方法 Download PDFInfo
- Publication number
- JP2013538827A JP2013538827A JP2013530180A JP2013530180A JP2013538827A JP 2013538827 A JP2013538827 A JP 2013538827A JP 2013530180 A JP2013530180 A JP 2013530180A JP 2013530180 A JP2013530180 A JP 2013530180A JP 2013538827 A JP2013538827 A JP 2013538827A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- urea
- probiotic
- nitrogen
- waste products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
【選択図】なし
Description
ヨーグルトまたはフローズンヨーグルトは、1ガロンの商業的に入手可能な、均質化され、殺菌された全乳から調製することができ、それを沸騰するまで加熱し、すぐに約45℃まで冷却する。これに約1オンスの、Lactobacillus属、Streptococcus属、Bacillus属またはBifidobacterium属の乳酸菌を含有するヨーグルトの種培養物を添加する。混合物をよく混ぜ、37℃で10から12時間発酵させる。1種または2種以上のタンパク質、プロバイオティクス、全果実添加物、フレーバリング剤、甘味剤、結合剤、または他の添加剤を組み合わせてヨーグルトに添加し、所望のかたさの製品を得る、または見込まれる消費者のパレット(the palette of the prospective consumer)に適合させることができる。本発明の一態様において、食品製品は、腎不全を有する個体の特別な食事のニーズに沿うような成分を含む。
ヘルスバーは、プロバイオティック(例えばLactobacillus属菌、Streptococcus属菌、Bacillus属菌またはBifidobacterium属菌)および大豆タンパク質単離物などのタンパク質と共に、結合剤、添加物、フレーバリング剤、着色料など様々な賦形剤を組み合わせ、柔軟な塊のかたさとなるまで混合することにより調製できる。その後、塊を押し出すか型に入れて、「キャンディバー」の形に成型し、その後乾燥または固化させて最終製品を形成する。
医療食品は、ロールドオート、乾燥リンゴ、蜂蜜、イヌリン、イナゴマメ粉、シナモン、糖、バニラ抽出物、およびホエータンパク質単離物などのタンパク質ならびにL. acidophilusおよび/またはL.fermentum、Bifidobacterium属菌およびStreptococcus thermophiles(それぞれ108〜1010cfu)の凍結乾燥した培養物を組み合わせて調製できる。これらの構成要素は適した比率でプレバイオティックと混合され、長さ約12.5から15センチメートル、幅3から4センチメートルおよび高さ1センチメートルの長方形の棒状に形成され、滅菌真空オーブン中に12から24時間おかれ、所望のかたさの可食性食品製品を得る。
ジェルカップ製品またはブタの食餌と混合した製剤の形態の本発明の組成物の効果を、Gottingen系統のミニブタにおける慢性尿毒症の確立されたモデル(Willis, et al. (1997) J. Endourol. 11(1):27-32)を用いて試験した。性的成熟期(3月齢)のこれらのブタは8〜11kgの重さであり、全ての他の系統のミニブタの半分のサイズである。このブタはゆっくり成長し、約6ヶ月で体重が2倍となる。
表1は、コンパニオンアニマルなどの動物への投与についての、栄養製品の好適なおおよその1回分の投与量を与える。
この例は、Streptococcus thermophilusの高レベルウレアーゼ分泌菌株の単離および選択を開示する。3種のグラム陽性、乳酸産生非病原性球菌のStreptococcus thermophilusの単離物を、様々な供給源から単離し、KB4、KB19およびKB25と指定した。KB4はプロバイオティック製品から単離し、KB19は市販のヨーグルト製品から、およびKB25は(インドからの)ダヒヨーグルトから単離した。
Claims (6)
- 少なくとも1種のプロバイオティック成分および少なくとも1種の単離された可食性タンパク質を含む、タンパク質豊富な栄養製品。
- プロバイオティック成分が、Lactobacillus属菌、Bacillus属菌、Streptococcus属菌、Bifidobacterium属菌、Saccharomyces属菌またはLeuconostoc属菌である、請求項1に記載の栄養製品。
- 少なくとも1種の単離されたタンパク質が、ホエータンパク質またはその単離物、濃縮物もしくは加水分解物;乳タンパク質またはその単離物、濃縮物もしくは加水分解物;ホエー成長因子抽出物;グルタミンペプチド;卵白;大豆タンパク質またはその単離物、濃縮物もしくは加水分解物;あるいはカゼイナートを含む、請求項1に記載の栄養製品。
- 血液から窒素含有老廃物を除去する方法であって、請求項1に記載の栄養製品の有効量を、それを必要とする対象に投与することを含み、それにより窒素含有老廃物を対象の血液から除去する、前記方法。
- 腎不全を改善する方法であって、請求項1に記載の栄養製品の有効量を、それを必要とする対象に投与することを含み、それにより腎不全を改善する、前記方法。
- 対象が、タンパク質欠乏症を有する、請求項5に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/890,951 | 2010-09-27 | ||
US12/890,951 US9980988B2 (en) | 2002-03-13 | 2010-09-27 | Compositions and methods for augmenting kidney function |
PCT/US2011/051171 WO2012050701A1 (en) | 2010-09-27 | 2011-09-12 | Compositions and methods for augmenting kidney function |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2013538827A true JP2013538827A (ja) | 2013-10-17 |
Family
ID=45938609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013530180A Pending JP2013538827A (ja) | 2010-09-27 | 2011-09-12 | 腎機能を増強させるための組成物および方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US9980988B2 (ja) |
EP (1) | EP2621285A4 (ja) |
JP (1) | JP2013538827A (ja) |
KR (2) | KR101940001B1 (ja) |
CN (1) | CN103228143A (ja) |
AU (1) | AU2011314299B2 (ja) |
CA (1) | CA2812909C (ja) |
WO (1) | WO2012050701A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI481409B (zh) * | 2013-01-10 | 2015-04-21 | Conmed Pharmaceutical & Bio Medical Corp | 一種使用益生菌製備用於清除尿毒素之組合物的用途 |
WO2018125735A1 (en) * | 2016-12-29 | 2018-07-05 | Kibow Biotech, Inc. | Composition and method for maintaining healthy kidney function |
KR102089836B1 (ko) * | 2017-03-15 | 2020-03-16 | (주)바이오일레븐 | 트립토판분해효소 음성균과 인터페론 감마 형성을 유도하는 균주를 이용한 염증성 질환 예방 및 치료용 약학적 조성물 또는 이를 이용한 치료방법 |
WO2019117654A1 (ko) * | 2017-12-15 | 2019-06-20 | (주)녹십자웰빙 | 신장질환 진행 억제 및 예방용 프로바이오틱스 및 이를 포함하는 신장질환 진행 억제 및 예방용 조성물 |
KR102215596B1 (ko) * | 2019-12-11 | 2021-02-15 | 주식회사 에이치이엠 | 신규한 스트렙토코커스 써모필러스 hem 14 균주, 및 상기 균주 또는 이의 배양물을 포함하는 장내 환경 개선용 조성물 |
KR102362828B1 (ko) | 2021-06-17 | 2022-02-15 | 주식회사 비피도 | 비피도박테리움 비피덤 bgn4를 함유한 신부전 개선용, 치료용 또는 예방용 조성물 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5816636A (ja) * | 1981-07-23 | 1983-01-31 | Nisshin Oil Mills Ltd:The | 乳酸発酵食品の製造法 |
US20020090416A1 (en) * | 1999-03-09 | 2002-07-11 | Philip Connolly | Method of enhancing absorption and utilization of protein |
WO2006035979A1 (ja) * | 2004-09-29 | 2006-04-06 | Asama Chemical Co., Ltd. | 乳清タンパク、乳由来の抗体または抗体を含む機能性組成物または食品 |
JP2007507526A (ja) * | 2003-09-30 | 2007-03-29 | キボー バイオテック、インク | 腎臓機能を増大させるための組成物および方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2414156A1 (de) * | 1974-03-23 | 1975-09-25 | Kleist Johann Georg Dr | Arzneimittel zur beseitigung uraemischer symptome und verfahren zu seiner herstellung |
US4218541A (en) * | 1978-03-30 | 1980-08-19 | Ackerman Roy A | Converting urea with bacteria |
DE3882057T2 (de) * | 1987-02-06 | 1994-01-20 | Nagase & Co | Verfahren zur Herstellung saurer Urease und ihre Verwendung. |
US5116737A (en) * | 1989-03-14 | 1992-05-26 | Chr. Hansen's Laboratory, Inc. | Method for growing acid-producing bacteria |
US5716615A (en) * | 1992-02-10 | 1998-02-10 | Renata Maria Anna Cavaliere Vesely | Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use |
US5258181A (en) * | 1992-03-02 | 1993-11-02 | The Procter & Gamble Company | Compositions containing psyllium |
IT1270216B (it) * | 1994-06-14 | 1997-04-29 | Recordati Chem Pharm | Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari |
WO1998030235A1 (fr) * | 1997-01-09 | 1998-07-16 | Morinaga Milk Industry Co., Ltd. | Comprimes de lactoferrine |
DE69929321T2 (de) | 1998-04-01 | 2006-09-14 | Ganeden Biotech, Inc., San Diego | Erfahren zür verringerung von cholesterin mit bacillus coagulans sporen, systeme un zusammensetzungen |
CA2374937A1 (en) | 1999-05-25 | 2000-11-30 | Gregor Reid | Oral administration of lactobacillus for the maintenance of health in women |
WO2000071139A2 (en) | 1999-05-25 | 2000-11-30 | Gregor Reid | Lactobacillus compositions and methods for preventing wound infections and biofilm formation on implantable surgical devices |
US6287609B1 (en) | 1999-06-09 | 2001-09-11 | Wisconsin Alumni Research Foundation | Unfermented gel fraction from psyllium seed husks |
IT1311495B1 (it) | 1999-06-09 | 2002-03-13 | Mendes S U R L | Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento. |
EP1145643A1 (en) | 2000-04-10 | 2001-10-17 | Phillip Connolly | Improved milk protein concentrate |
US20030077255A1 (en) * | 2001-04-16 | 2003-04-24 | Sabharwal Hemant K. | Compositions of bacteria and alpha-lactalbumin and uses thereof |
BG108449A (en) * | 2003-12-15 | 2005-06-30 | АЛЕКСАНДРОВ Никола | Synbiotic product and its administration as carrier of natural bioactive substances in functional food additives |
JP2006094739A (ja) * | 2004-09-29 | 2006-04-13 | Asama Chemical Co Ltd | 乳清タンパク・ココア食品 |
CA2673120C (en) * | 2006-12-18 | 2012-08-07 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
-
2010
- 2010-09-27 US US12/890,951 patent/US9980988B2/en active Active
-
2011
- 2011-09-12 CN CN2011800567736A patent/CN103228143A/zh active Pending
- 2011-09-12 KR KR1020177037864A patent/KR101940001B1/ko active IP Right Grant
- 2011-09-12 CA CA2812909A patent/CA2812909C/en active Active
- 2011-09-12 AU AU2011314299A patent/AU2011314299B2/en active Active
- 2011-09-12 JP JP2013530180A patent/JP2013538827A/ja active Pending
- 2011-09-12 KR KR1020137010809A patent/KR20140026326A/ko not_active Application Discontinuation
- 2011-09-12 US US13/825,985 patent/US20140161780A1/en not_active Abandoned
- 2011-09-12 EP EP11832930.9A patent/EP2621285A4/en not_active Withdrawn
- 2011-09-12 WO PCT/US2011/051171 patent/WO2012050701A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5816636A (ja) * | 1981-07-23 | 1983-01-31 | Nisshin Oil Mills Ltd:The | 乳酸発酵食品の製造法 |
US20020090416A1 (en) * | 1999-03-09 | 2002-07-11 | Philip Connolly | Method of enhancing absorption and utilization of protein |
JP2007507526A (ja) * | 2003-09-30 | 2007-03-29 | キボー バイオテック、インク | 腎臓機能を増大させるための組成物および方法 |
WO2006035979A1 (ja) * | 2004-09-29 | 2006-04-06 | Asama Chemical Co., Ltd. | 乳清タンパク、乳由来の抗体または抗体を含む機能性組成物または食品 |
Non-Patent Citations (2)
Title |
---|
KRENITSKY J.: "Nutrition in Renal Failure: Myths and Management", PRACTICAL GASTROENTEROLOGY, JPN6016010562, September 2004 (2004-09-01), pages 40 - 42, ISSN: 0003280830 * |
THE SCIENTIFIC WORLD JOURNAL, vol. 5, JPN6015028193, 2005, pages 652 - 60, ISSN: 0003115413 * |
Also Published As
Publication number | Publication date |
---|---|
KR20140026326A (ko) | 2014-03-05 |
KR101940001B1 (ko) | 2019-01-18 |
EP2621285A1 (en) | 2013-08-07 |
EP2621285A4 (en) | 2015-09-30 |
US20140161780A1 (en) | 2014-06-12 |
AU2011314299B2 (en) | 2015-01-29 |
AU2011314299A1 (en) | 2013-05-02 |
US9980988B2 (en) | 2018-05-29 |
KR20180004840A (ko) | 2018-01-12 |
CA2812909C (en) | 2019-08-13 |
CA2812909A1 (en) | 2012-04-19 |
US20110097307A1 (en) | 2011-04-28 |
WO2012050701A1 (en) | 2012-04-19 |
CN103228143A (zh) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8481025B2 (en) | Composition for maintaining healthy kidney function | |
US20180207165A1 (en) | Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract | |
US9655932B2 (en) | Composition and method for preventing or treating gout or hyperuricemia | |
TWI594758B (zh) | 包含雙歧桿菌的組合物、其製備方法及其用途 | |
US20100166721A1 (en) | Probotic compositions and uses thereof | |
US11103542B2 (en) | Composition and method for maintaining healthy kidney function | |
US20110165127A1 (en) | Dairy-derived probiotic compositions and uses thereof | |
JP2009511469A (ja) | 脂肪代謝及び肥満に影響を及ぼすプロバイオティクス | |
JP2011500821A (ja) | 減量を誘発及び援助するためのプロバイオティック組成物及び方法 | |
CA3017371A1 (en) | Food compositions for weaning | |
EP1374878A1 (en) | Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract | |
AU2011314299B2 (en) | Compositions and methods for augmenting kidney function | |
CA2478991C (en) | Compositions and methods for augmenting kidney function | |
US11179426B2 (en) | Composition and method for maintaining healthy kidney function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140825 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150713 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20151013 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20151113 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20151214 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160113 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160318 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160620 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20160818 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20161122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20170322 |